LINE-1 expression in cancer correlates with p53 mutation, copy number alteration, and S phase checkpoint

Authors

Wilson McKerrow, New York University
Xuya Wang, New York University
Carlos Mendez-Dorantes, Harvard University
Paolo Mita, New York University
Song Cao, Washington University School of Medicine in St. Louis
Mark Grivainis, New York University
Li Ding, Washington University School of Medicine in St. Louis
John LaCava, The Rockefeller University
Kathleen H Burns, Harvard University
Jef D Boeke, New York University
David Fenyö, New York University

Journal

Proceedings of the National Academy of Sciences of the United States of America

Publication Date

2-22-2022

Volume

119

Issue

8

First Page

e2115999119

Document Type

Open Access Publication

DOI

10.1073/pnas.2115999119

Rights and Permissions

McKerrow W, Wang X, Mendez-Dorantes C, Mita P, Cao S, Grivainis M, Ding L, LaCava J, Burns KH, Boeke JD, Fenyö D. LINE-1 expression in cancer correlates with p53 mutation, copy number alteration, and S phase checkpoint. Proc Natl Acad Sci U S A. 2022 Feb 22;119(8):e2115999119. doi: 10.1073/pnas.2115999119. This article is distributed underCreative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).

Recommended Citation

McKerrow, Wilson; Wang, Xuya; Mendez-Dorantes, Carlos; Mita, Paolo; Cao, Song; Grivainis, Mark; Ding, Li; LaCava, John; Burns, Kathleen H; Boeke, Jef D; and Fenyö, David, "LINE-1 expression in cancer correlates with p53 mutation, copy number alteration, and S phase checkpoint." Proceedings of the National Academy of Sciences of the United States of America. 119, 8. e2115999119 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11414